Nicoletta Carlo-Stella

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: LinkedIn

Nicoletta Carlo-Stella, MD, PhD, (b. 1966) is a rheumatologist with the Internal Medicine Department at a hospital in Pavia, Italy.[1][2]

She is one of the authors of the 2011 case definition, International Consensus Criteria.[3]


Studies[edit | edit source]

  • 2004, Chronic fatigue syndrome: a review[4](Abstract)
  • 2006, A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles.[5]
  • 2009, Demographic and clinical aspects of an Italian patient population with chronic fatigue syndrome.[6]
  • 2009, Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome.[7]
  • 2010, Letter to the editor re: "A formal analysis of cytokine networks in chronic fatigue syndrome" by Broderick et al.[8]
  • 2011, Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: a two‑edged weapon in chronic fatigue syndrome.[9]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

References[edit | edit source]

  1. https://it.linkedin.com/in/nicoletta-carlo-stella-b0044323
  2. http://prabook.com/web/person-view.html?profileId=157252
  3. Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A. C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (Aug 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890Freely accessible. PMID 21777306. 
  4. Carlo-Stella, N; Lorusso, L; Candura, SM; Cuccia, M (2004), "Chronic fatigue syndrome: a review", Recenti Prog Med, 96 (11): 546-52, PMID 15598093 
  5. Carlo-Stella, N; Badulli, C; De Silvestri, A; Bazzichi, L; Martinetti, M; Lorusso, L; Bombardieri, S; Salvaneschi, L; Cuccia, M (2006), "A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles", Clinical and Experimental Rheumatology, 24 (2): 179-82, PMID 16762155 
  6. Carlo-Stella, N; Cuccia, M (2009), "Demographic and clinical aspects of an Italian patient population with chronic fatigue syndrome.", Reumatismo, 61 (4): 285-9, doi:10.4081/reumatismo.2009.285 
  7. Carlo-Stella, N; Bozzini, S; De Silvestri, A; Sbarsi, I; Pizzochero, C; Lorusso, L; Martinetti, M; Cuccia, M (2009), "Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome", International Journal of Immunopathology and Pharmacology, 22 (3): 745-54, doi:10.1177/039463200902200320, PMID 19822091 
  8. Carlo-Stella N. (2010) Letter to the editor re: "A formal analysis of cytokine networks in chronic fatigue syndrome" by Broderick et al. Brain, Behavior, and Immunity, 24 (7):1218; author reply 1219. doi: 10.1016/j.bbi.2010.06.004. Epub 2010 Jun 16.Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20561580
  9. Pasi, A; Bozzini, S; Carlo-Stella, N; Martinetti, M; Bombardieri, S; De Silvestri, A; Salvaneschi, L; Cuccia, M (2011), "Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: a two‑edged weapon in chronic fatigue syndrome", Molecular Medicine Reports, 4 (3): 535-40, doi:10.3892/mmr.2011.447 

chronic fatigue syndrome (CFS) - A controversial term, invented by the U.S. Centers for Disease Control, that generally refers to a collection of symptoms as “fatigue”. There have been multiple attempts to come up with a set of diagnostic criteria to define this term, but few of those diagnostic criteria are currently in use. Previous attempts to define this term include the Fukuda criteria and the Oxford criteria. Some view the term as a useful diagnostic category for people with long-term fatigue of unexplained origin. Others view the term as a derogatory term borne out of animus towards patients. Some view the term as a synonym of myalgic encephalomyelitis, while others view myalgic encephalomyelitis as a distinct disease.

chronic fatigue syndrome (CFS) - A controversial term, invented by the U.S. Centers for Disease Control, that generally refers to a collection of symptoms as “fatigue”. There have been multiple attempts to come up with a set of diagnostic criteria to define this term, but few of those diagnostic criteria are currently in use. Previous attempts to define this term include the Fukuda criteria and the Oxford criteria. Some view the term as a useful diagnostic category for people with long-term fatigue of unexplained origin. Others view the term as a derogatory term borne out of animus towards patients. Some view the term as a synonym of myalgic encephalomyelitis, while others view myalgic encephalomyelitis as a distinct disease.

human leukocyte antigen complex (HLA) - A set of genes responsible for a given person's immune response to potential threats. Specifically, HLA genes encode proteins which help the immune system to distinguish the body's own proteins from proteins which are made by foreign invaders like bacteria and viruses. The HLA complex can vary greatly from person to person, generating unique immune and allergic responses. (Learn more: mecfsresearchreview.me)

antibody - Antibodies or immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

chronic fatigue syndrome (CFS) - A controversial term, invented by the U.S. Centers for Disease Control, that generally refers to a collection of symptoms as “fatigue”. There have been multiple attempts to come up with a set of diagnostic criteria to define this term, but few of those diagnostic criteria are currently in use. Previous attempts to define this term include the Fukuda criteria and the Oxford criteria. Some view the term as a useful diagnostic category for people with long-term fatigue of unexplained origin. Others view the term as a derogatory term borne out of animus towards patients. Some view the term as a synonym of myalgic encephalomyelitis, while others view myalgic encephalomyelitis as a distinct disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.